Drug delivery with topically applied nanoparticles: Science fiction or reality?

Skin Pharmacology and Physiology

Volumn 26, Issue 4-6, 2013, Pages 227-233

  Lademann, J ^a   Richter, H ^a   Meinke, M C ^a   Lange Asschenfeldt, B ^a   Antoniou, C ^b   Mak, W C ^c   Renneberg, R ^c   Sterry, W ^a   Patzelt, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ATHENS   (Greece)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Follicular penetration; Hair follicle; Triggered drug release

Indexed keywords

CAFFEINE; MINOXIDIL; NANOPARTICLE;

ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG PENETRATION; DRUG RELEASE; HAIR FOLLICLE; HUMAN; PRIORITY JOURNAL; SURFACE PROPERTY; TARGET CELL; CHEMICAL STRUCTURE; FLUORESCENCE; IMMUNOMODULATION; LASER MICROSCOPY; NONHUMAN; SCANNING ELECTRON MICROSCOPY;

ADMINISTRATION, CUTANEOUS; ANIMALS; BIOLOGICAL TRANSPORT; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HAIR FOLLICLE; HUMANS; LIPOSOMES; NANOPARTICLES; PARTICLE SIZE; SKIN; SKIN ABSORPTION;

EID: 84881398902     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000351940     Document Type: Article

References (54)

1. Beani JC: Solar protection products: efficacy and risks (in French). Ann Dermatol Venereol 2012; 139: 261-272.
2. Darvin ME, Konig K, Kellner-Hoefer M, Breunig HG, Werncke W, Meinke MC, Patzelt A, Sterry W, Lademann J: Safety assessment by multiphoton fluorescence/second harmonic generation/hyper-Rayleigh scattering tomography of ZNO nanoparticles used in cosmetic products. Skin Pharmacol Physiol 2012; 25: 219-226.
3. Guerrero S, Araya E, Fiedler JL, Arias JI, Adura C, Albericio F, Giralt E, Arias JL, Fernandez MS, Kogan MJ: Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide. Nanomedicine (Lond) 2010; 5: 897-913.
4. Koffie RM, Farrar CT, Saidi LJ, William CM, Hyman BT, Spires-Jones TL: Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging. Proc Natl Acad Sci US A 2011; 108: 18837-18842.
5. Labouta HI, El-Khordagui LK, Schneider M: Could chemical enhancement of gold nanoparticle penetration be extrapolated from established approaches for drug permeation? Skin Pharmacol Physiol 2012; 25: 208-218.
6. Park K: No penetration of nanoparticles through intact skin. J Control Release 2012; 162: 258.
7. Schlupp P, Blaschke T, Kramer KD, Holtje HD, Mehnert W, Schafer-Korting M: Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids. Skin Pharmacol Physiol 2011; 24: 199-209.
8. Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L: Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 2012; 17: 5972-5987.
9. Li S, Qiu YQ, Zhang SH, Gao YH: A novel transdermal fomulation of 18beta-glycyrrhetic acid with lysine for improving bioavailability and efficacy. Skin Pharmacol Physiol 2012; 25: 257-268.
10. Li N, Peng LH, Chen X, Nakagawa S, Gao JQ: Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo. Int J Nanomed 2011; 6: 3241-3250.
11. Bouwstra JA, Honeywell-Nguyen PL: Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 2002; 54(suppl 1):S41-55.
12. Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Monkkonen J: Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 1999; 7: 279-286.
13. Weiner N, Lieb L, Niemiec S, Ramachandran C, Hu Z, Egbaria K: Liposomes: a novel topical delivery system for pharmaceutical and cosmetic applications. J Drug Target 1994; 2: 405-410.
14. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM: Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007; 332: 1-16.
15. Scalia S, Mezzena M, Ramaccini D: Encapsulation of the UV filters ethylhexyl methoxycinnamate and butyl methoxydibenzoylmethane in lipid microparticles: effect on in vivo human skin permeation. Skin Pharmacol Physiol 2011; 24: 182-189.
16. Wang SQ, Tooley IR: Photoprotection in the era of nanotechnology. Semin Cutan Med Surg 2011; 30: 210-213.
17. Campbell CS, Contreras-Rojas LR, Delgado-Charro MB, Guy RH: Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. J Control Release 2012; 162: 201-207.
18. Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, Weiss B, Schaefer UF, Lehr CM, Wepf R, Sterry W: Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 2007; 66: 159-164.
19. Miquel-Jeanjean C, Crepel F, Raufast V, Payre B, Datas L, Bessou-Touya S, Duplan H: Penetration study of formulated nanosized titanium dioxide in models of damaged and sunirradiated skins. Photochem Photobiol 2012; 88: 1513-1521.
20. Mortensen LJ, Oberdorster G, Pentland AP, Delouise LA: In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett 2008; 8: 2779-2787.
21. Smijs TG, Bouwstra JA: Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. J Biomed Nanotechnol 2010; 6: 469-484.
22. Lee WR, Shen SC, Al-Suwayeh SA, Yang HH, Li YC, Fang JY: Skin permeation of smallmolecule drugs, macromolecules, and nanoparticles mediated by a fractional carbon dioxide laser: the role of hair follicles. Pharm Res 2013; 30: 792-802.
23. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H: Skin penetration and distribution of polymeric nanoparticles. J Control Release 2004; 99: 53-62.
24. Blume-Peytavi U, Vogt A: Human hair follicle: reservoir function and selective targeting. Br J Dermatol 2011; 165(suppl 2):13-17.
25. Jung S, Patzelt A, Otberg N, Thiede G, Sterry W, Lademann J: Strategy of topical vaccination with nanoparticles. J Biomed Opt 2009; 14: 021001.
26. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EM, Yoong C, Robertson TA, Soyer HP, Roberts MS: Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 2011; 63: 470-491.
27. Bonnist EY, Gorce JP, Mackay C, Pendlington RU, Pudney PD: Measuring the penetration of a skin sensitizer and its delivery vehicles simultaneously with confocal Raman spectroscopy. Skin Pharmacol Physiol 2011; 24: 274-283.
28. Jacobi U, Schanzer S, Weigmann HJ, Patzelt A, Vergou T, Sterry W, Lademann J: Pathways of lateral spreading. Skin Pharmacol Physiol 2011; 24: 231-237.
29. Wohlrab J, Klapperstuck T, Reinhardt HW, Albrecht M: Interaction of epicutaneously applied lipids with stratum corneum depends on the presence of either emulsifiers or hydrogenated phosphatidylcholine. Skin Pharmacol Physiol 2010; 23: 298-305.
30. Luther N, Darvin ME, Sterry W, Lademann J, Patzelt A: Ethnic differences in skin physiology, hair follicle morphology and follicular penetration. Skin Pharmacol Physiol 2012; 25: 182-191.
31. Schroeter A, Engelbrecht T, Neubert RH, Goebel AS: New nanosized technologies for dermal and transdermal drug delivery. A review. J Biomed Nanotechnol 2010; 6: 511-528.
32. Stahl J, Niedorf F, Wohlert M, Kietzmann M: The in vitro use of the hair follicle closure technique to study the follicular and percutaneous permeation of topically applied drugs. Altern Lab Anim 2012; 40: 51-57.
33. Lademann J, Patzelt A, Schanzer S, Richter H, Gross I, Menting KH, Frazier L, Sterry W, Antoniou C: Decontamination of the skin with absorbing materials. Skin Pharmacol Physiol 2011; 24: 87-92.
34. Mahe B, Vogt A, Liard C, Duffy D, Abadie V, Bonduelle O, Boissonnas A, Sterry W, Verrier B, Blume-Peytavi U, Combadiere B: Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol 2009; 129: 1156-1164.
35. Wosicka H, Cal K: Targeting to the hair follicles: current status and potential. J Dermatol Sci 2010; 57: 83-89.
36. Otberg N, Patzelt A, Rasulev U, Hagemeister T, Linscheid M, Sinkgraven R, Sterry W, Lademann J: The role of hair follicles in the percutaneous absorption of caffeine. Br J Clin Pharmacol 2008; 65: 488-492.
37. Blume-Peytavi U, Massoudy L, Patzelt A, Lademann J, Dietz E, Rasulev U, Garcia Bartels N: Follicular and percutaneous penetration pathways of topically applied minoxidil foam. Eur J Pharm Biopharm 2010; 76: 450-453.
38. Teichmann A, Otberg N, Jacobi U, Sterry W, Lademann J: Follicular penetration: Development of a method to block the follicles selectively against the penetration of topically applied substances. Skin Pharmacol Physiol 2006; 19: 216-223.
39. Liu X, Grice JE, Lademann J, Otberg N, Trauer S, Patzelt A, Roberts MS: Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man. Br J Clin Pharmacol 2011; 72: 768-774.
40. Lademann J, Richter H, Schaefer UF, Blume-Peytavi U, Teichmann A, Otberg N, Sterry W: Hair follicles-a long-term reservoir for drug delivery. Skin Pharmacol Physiol 2006; 19: 232-236.
41. Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J: Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 2004; 122: 14-19.
42. Lademann J, Patzelt A, Schanzer S, Richter H, Thiede G, Havlickova B, Gunther C, Friedrich M, Sterry W, Fluhr JW, Seifert S: Non-invasive analysis of penetration and storage of isoconazole nitrate in the stratum corneum and the hair follicles. Eur J Pharm Biopharm 2012; 80: 615-620.
43. Lademann J, Richter H, Meinke M, Sterry W, Patzelt A: Which skin model is the most appropriate for the investigation of topically applied substances into the hair follicles? Skin Pharmacol Physiol 2010; 23: 47-52.
44. Patzelt A, Richter H, Buettemeyer R, Huber HJ, Blume-Peytavi U, Sterry W, Lademann J: Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. Eur J Pharm Biopharm 2008; 70: 234-238.
45. Teichmann A, Jacobi U, Ossadnik M, Richter H, Koch S, Sterry W, Lademann J: Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol 2005; 125: 264-269.
46. Garcia Ortiz P, Hansen SH, Shah VP, Sonne J, Benfeldt E: Are marketed topical metronidazole creams bioequivalent? Evaluation by in vivo microdialysis sampling and tape stripping methodology. Skin Pharmacol Physiol 2011; 24: 44-53.
47. Mills OH Jr, Kligman AM: The follicular biopsy. Dermatologica 1983; 167: 57-63.
48. Patzelt A, Richter H, Daehne L, Walden P, Wiesmueller K-H, Wank U, Sterry W, Lademann J: Influence of the vehicle on the penetration of particles into the hair follicles. Pharmaceutics 2011; 3: 307-314.
49. Patzelt A, Richter H, Knorr F, Schafer U, Lehr CM, Dahne L, Sterry W, Lademann J: Selective follicular targeting by modification of the particle sizes. J Control Release 2011; 150: 45-48.
50. Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, Autran B, Sterry W, Blume-Peytavi U: 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 2006; 126: 1316-1322.
51. Frum Y, Bonner MC, Eccleston GM, Meidan VM: The influence of drug partition coefficient on follicular penetration: in vitro human skin studies. Eur J Pharm Sci 2007; 30: 280-287.
52. Raufast V, Mavon A: Transfollicular delivery of linoleic acid in human scalp skin: permeation study and microautoradiographic analysis. Int J Cosmet Sci 2006; 28: 117-123.
53. Mak WC, Richter H, Patzelt A, Sterry W, Lai KK, Renneberg R, Lademann J: Drug delivery into the skin by degradable particles. Eur J Pharm Biopharm 2011; 79: 23-27.
54. Mak WC, Patzelt A, Richter H, Renneberg R, Lai KK, Ruhl E, Sterry W, Lademann J: Triggering of drug release of particles in hair follicles. J Control Release 2012; 160: 509-514.